Literature DB >> 132270

Kinetics of induction and growth of enzyme-deficient islands involved in hepatocarcinogenesis.

E Scherer, P Emmelot.   

Abstract

A single application of various hepatocarcinogens to rats results in the formation of islands of enzyme-deficient liver cells, which are mainly irreversible and very probably represent the first cellular stage involved in the process of liver cancer formation. Comparison of the island-size distributions obtained for different carcinogens indicated that proliferation is a common property of islands that is independent of the inducing carcinogen and does not need any further presence of carcinogen or other stimulating factors. Toxic doses resulted in all cases in an enhanced island size. The number of islands induced by a single dose of carcinogen was enhanced by a prior partial hepatectomy only in the case of the dialkylnitrosamines, dimethylnitrosamine, and diethylnitrosamine. Dose-response relationships measured with diethylnitrosamine, the carcinogen with the lowest toxicity as compared with the carcinogenic action, indicated that island formation is due to a one-hit process, i.e., that one specific alteration in the target cell is responsible for the precancerous transformation. These kinetics and the low probability of transformation might indicate that the crucial hit is scored at the genetic level. The irreversible action of carcinogen (memory effect) and the influence of time on cancer formation (time effect) are discussed in terms of induction and proliferation of irreversible cell populations serving as precursor of the cancer cell. The number of specific alterations (hits) involved in the development of the malignant cancer cell is also briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 132270

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  Immunocytochemical investigation of alpha-fetoprotein-positive cells in hepatocarcinogenesis and hepatomas induced by 3'-ME-DAB.

Authors:  M Iwai
Journal:  Gastroenterol Jpn       Date:  1983-08

Review 2.  Chemical carcinogenesis: a biologic perspective.

Authors:  E Farber
Journal:  Am J Pathol       Date:  1982-02       Impact factor: 4.307

Review 3.  Cytochemical and biochemical microanalysis of carcinogenesis.

Authors:  P Bannasch; U Benner; H J Hacker; F Klimek; D Mayer; M Moore; H Zerban
Journal:  Histochem J       Date:  1981-09

4.  Heterogeneity of hepatocyte antigen expression in rat liver carcinogenesis: concordance between neoplastic nodules and tumours.

Authors:  M J Embleton; H S James; A J Haynes; P C Butler
Journal:  Br J Exp Pathol       Date:  1989-12

5.  Age-, sex-, and strain-dependent differences in the induction of enzyme-altered islands in rat liver by diethylnitrosamine.

Authors:  E Deml; D Oesterle; T Wolff; H Greim
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

Review 6.  Enzymes of glutathione metabolism as biochemical markers during hepatocarcinogenesis.

Authors:  S Hendrich; H C Pitot
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

7.  Trichloroethylene effects on the formation of enzyme-altered foci in rat liver.

Authors:  M M Milks; D Couri
Journal:  Arch Toxicol       Date:  1984-12       Impact factor: 5.153

8.  [Neoplastic and preneoplastic lesions in rats after oral administration of a single dose of N-nitrosomorpholine (author's transl)].

Authors:  P Bannasch; D Mayer; R Krech
Journal:  J Cancer Res Clin Oncol       Date:  1979-07-27       Impact factor: 4.553

9.  The nature and significance of liver cell vacuolation following hepatocellular injury--an analysis based on observations on rats rendered tolerant to hepatotoxic damage.

Authors:  N C Nayak; S A Sathar; S Mughal; S Duttagupta; M Mathur; P Chopra
Journal:  Virchows Arch       Date:  1996-08       Impact factor: 4.064

10.  Models for analyzing data in initiation-promotion studies.

Authors:  C Chen; H Gibb; A Moini
Journal:  Environ Health Perspect       Date:  1991-01       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.